Showing results (1421-1430 of 1,443) with videos related to

Sort By:
Pageof 145
Nature Medicine|May 14, 2026
Advancing conversational diagnostic AI with multimodal reasoningKhaled Saab, Chunjong Park, Tim Strother, et al.
Scientific Reports|June 2, 2026
Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008)Jin-Wei Wu, Da-Long Yang, Shu-Chang Chen, et al.
Nature Genetics|July 12, 2016
Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptationLi Yu, Guo-Dong Wang, Jue Ruan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interspecies regulatory landscapes and elements revealed by novel joint systematic integration of human and mouse blood cell epigenomesGuanjue Xiang, Xi He, Belinda M Giardine, et al.
Genome Research|July 1, 2024
Interspecies regulatory landscapes and elements revealed by novel joint systematic integration of human and mouse blood cell epigenomesGuanjue Xiang, Xi He, Belinda M Giardine, et al.
Nature|August 29, 2014
Comparative analysis of regulatory information and circuits across distant speciesAlan P Boyle, Carlos L Araya, Cathleen Brdlik, et al.
Hepatology (Baltimore, Md.)|February 5, 2025
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesDa-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Cell|March 20, 2012
Personal omics profiling reveals dynamic molecular and medical phenotypesRui Chen, George I Mias, Jennifer Li-Pook-Than, et al.
Nature Communications|April 16, 2015
Whole-exome sequencing implicates UBE3D in age-related macular degeneration in East Asian populationsLv-Zhen Huang, Ying-Jie Li, Xue-Feng Xie, et al.
Liver Cancer|June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter StudyDa-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Pageof 145